Rapid Point-of-Care Electrochemical Sensor for the Detection of Cancer Tn Antigen Carbohydrate in Whole Unprocessed Blood.
Saimon Moraes SilvaDaniel P LangleyLuke R CossinsAnushka N SamudraAnita F QuigleyRobert M I KapsaRichard W TothillGeorge W GreeneSimon E MoultonPublished in: ACS sensors (2022)
Improving outcomes for cancer patients during treatment and monitoring for cancer recurrence requires personalized care which can only be achieved through regular surveillance for biomarkers. Unfortunately, routine detection for blood-based biomarkers is cost-prohibitive using currently specialized laboratories. Using a rapid self-assembly sensing interface amenable to methods of mass production, we demonstrate the ability to detect and quantify a small carbohydrate-based cancer biomarker, Tn antigen (αGalNAc-Ser/Thr) in a small volume of blood, using a test format strip reminiscent of a blood glucose test. The detection of Tn antigen at picomolar levels is achieved through a new transduction mechanism based on the impact of Tn antigen interactions on the molecular dynamic motion of a lectin cross-linked lubricin antifouling brush. In tests performed on retrospective blood plasma samples from patients presenting three different tumor types, differentiation between healthy and diseased patients was achieved, highlighting the clinical potential for cancer monitoring.
Keyphrases
- papillary thyroid
- end stage renal disease
- loop mediated isothermal amplification
- squamous cell
- blood glucose
- ejection fraction
- newly diagnosed
- prognostic factors
- chronic kidney disease
- palliative care
- peritoneal dialysis
- public health
- type diabetes
- squamous cell carcinoma
- blood pressure
- patient reported outcomes
- real time pcr
- skeletal muscle
- molecularly imprinted
- pain management
- case report
- weight loss
- glycemic control
- young adults
- sensitive detection